- Nextleaf Solutions Ltd. (OILS) rolls out distilled CBD 100 and 200 oil to patients through its distribution partner, Medicibis
- Glacial Gold™ CBD distilled oils are formulated with organic coconut MCT oil and a standardized dose of CBD
- The product has the highest potency of CBD available in an ingestible form and the best dollar value per milligram
- All Glacial Gold™ CBD and THC vapes and distilled oils are distributed by Medicibis patients in Quebec and across Canada
- Nextleaf Solutions Ltd. (OILS) is up 2.94 per cent trading at $0.18 per share as of 2:02 p.m. EST
Nextleaf Solutions Ltd. (OILS) has rolled out distilled CBD 100 and 200 oil to patients through its distribution partner, Medicibis.
Glacial Gold™ CBD distilled oils are formulated with organic coconut MCT oil and a standardized dose of CBD.
Glacial Gold™Distilled CBD Oil has the highest potency of CBD available in an ingestible format.
It also has the best dollar value per milligram for CBD in Canada.
In British Columbia, Nextleaf is a top 10 supplier of vapes and oils.
Glacial Gold™ has multiple products inside the top 20 best-selling products in the vape and oils categories.
All Glacial Gold™ CBD and THC vapes and distilled oils are distributed by Medicibis patients in Quebec and across Canada.
Quebec is the third-largest cannabis market in Canada.
A study in 2019 recorded that 96 per cent of veterans say they experience a greater quality of life because of their cannabis consumption.
Nextleaf launched an assortment of well-priced Glacial Gold™ CBD and THC products for the medical market through Mendo.
Canadian spending on medical cannabis totalled $587 million in 2020.
Medical cannabis saw $119 million of purchases reimbursed by the Federal Government through Veterans Affairs Canada in 2020.
CBD is also becoming a candidate as a potential therapeutic treatment for opioid use disorder.
Earlier this month the FDA approved human trials evaluating an investigational drug-using CBD to be conducted at UCLA.
It will be funded by the U.S. National Institute on Drug Abuse.
Nextleaf Solutions Ltd. (OILS) is up 2.94 per cent trading at $0.18 per share as of 2:02 p.m. EST.